Drug Approval | June 06, 2022
FDA publishes ANP’s polymeric drug excipient DMF
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The rally attracted around 250 riders, including professionals and amateurs.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
AstraZeneca also played a critical role in the global response to COVID-19.
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
Subscribe To Our Newsletter & Stay Updated
